TheProfitWatch

VSTM - Verastem, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
9.62 0.44 (4.6%) 0.0 (-0.02%) -0.04 (-0.37%) 0.11 (1.08%) 0.12 (1.25%) 0.37 (3.85%) -0.01 (-0.1%) 0.09 (0.93%)

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.39
Diluted EPS:
-0.62
Basic P/E:
-25.8026
Diluted P/E:
-16.2306
RSI(14) 1m:
69.52
VWAP:
10.07
RVol:

Events

Period Kind Movement Occurred At

Related News